Global Agoraphobia Treatment Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Agoraphobia Treatment Market

Agoraphobia treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.2% in the above mentioned forecast period.

Agoraphobia is a rare type of anxiety disorder which is characterised by anxiety and phobia of being in situations where it is difficult to emigrate or when aid may be unavailable. Fear of crowds, bridges or of being outside alone is included in agoraphobia. Symptoms of this neurological disorder involve panic attack, rapid heart rate, dizziness, hyperventilation, flushing, hyperhidrosis, diarrhea, trembling, nausea and problems related to swallowing.

Rise in the prevalence of agoraphobia due to growing incidence of stress or anxiety are the driving factors that will influence the market growth. Also, genetic predisposition, sedentary lifestyles, growing healthcare expenditure, deteriorating health standards in the contemporary lifestyles, rising awareness and screening are the factors that will expand the agoraphobia treatment market.

Rise in the research and development activities and emerging new markets will provide beneficial opportunities for the agoraphobia treatment market in the forecast period of 2021-2028.

However, the high cost of treatment, social stigma regarding psychotherapy, reluctance to therapy, and treatment are the factors that will hinder the market growth. Low focus and penetration of mental health in society will challenge the agoraphobia treatment market in the forecast period mentioned above.

This agoraphobia treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the agoraphobia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Agoraphobia Treatment Market Scope and Market Size

The agoraphobia treatment market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the agoraphobia treatment market is segmented into therapy, medication and others. Therapy has been further sub-segmented into psychotherapy, exposure therapy and cognitive behavioral therapy. Medication has been further sub-segmented into anti-anxiety medications, tricyclic antidepressants, selective serotonin reuptake inhibitors and norepinephrine reuptake inhibitors.
• On the basis of diagnosis, the agoraphobia treatment market is segmented into blood tests, physical examination and others.
• On the basis of symptoms, the agoraphobia treatment market is segmented into panic attack, rapid heart rate, dizziness, hyperventilation, flushing, hyperhidrosis, diarrhea, trembling, nausea and others.
• On the basis of dosage, the agoraphobia treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the agoraphobia treatment market is segmented into oral, intravenous, intramuscular and others.
• On the basis of end-users, the agoraphobia treatment market is segmented into clinic, hospital and others.

The agoraphobia treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Agoraphobia Treatment Market Country Level Analysis

Agoraphobia treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the agoraphobia treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the agoraphobia treatment market due to the presence of major key players, growing focus of government on R&D activities and on the mental health, rise in the prevalence of agoraphobia. Furthermore, favourable reimbursement scenario and well-developed healthcare sector will contribute in the growth of market in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, increasing disposable income, more investment in the healthcare sector, rising awareness and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Agoraphobia treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Agoraphobia Treatment Market Share Analysis

Agoraphobia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global agoraphobia treatment market research.

The major players covered in the agoraphobia treatment market report are Lilly, GlaxoSmithKline plc, Pfizer Inc., AstraZeneca, Johnson & Johnson Private Limited, Bristol-Myers Squibb Company,   Sandoz International GmbH, Apotex Inc., Mylan N.V., H. Lundbeck A/S, Allergan, Sanofi, Merck Sharp & Dohme Corp., Teva Pharmaceutical Industries Ltd., Alkermes, Takeda Pharmaceutical Company Limited., OPKO Health, Inc., Intra-Cellular Therapies Inc., Janssen Pharmaceuticals, Inc., Lupin, Novartis AG, and Bausch Health Companies Inc., among other domestic and global players.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-66744